Jia Gu

694 total citations
33 papers, 428 citations indexed

About

Jia Gu is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Jia Gu has authored 33 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Immunology and 11 papers in Molecular Biology. Recurrent topics in Jia Gu's work include Immune Cell Function and Interaction (11 papers), Autoimmune and Inflammatory Disorders Research (7 papers) and CAR-T cell therapy research (6 papers). Jia Gu is often cited by papers focused on Immune Cell Function and Interaction (11 papers), Autoimmune and Inflammatory Disorders Research (7 papers) and CAR-T cell therapy research (6 papers). Jia Gu collaborates with scholars based in China. Jia Gu's co-authors include Qin Li, Neng Zhu, Hongfang Li, Duan‐Fang Liao, Tanjun Zhao, Chanjuan Zhang, Min Xiao, Jianfeng Zhou, Yaning Shi and Xiaolu Long and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Journal of Allergy and Clinical Immunology.

In The Last Decade

Jia Gu

30 papers receiving 424 citations

Peers

Jia Gu
Qi Zhu China
Alessandro Barbarulo United Kingdom
Kimberly Boelte United States
Chun Chen China
Qi Zhu China
Jia Gu
Citations per year, relative to Jia Gu Jia Gu (= 1×) peers Qi Zhu

Countries citing papers authored by Jia Gu

Since Specialization
Citations

This map shows the geographic impact of Jia Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jia Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jia Gu more than expected).

Fields of papers citing papers by Jia Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jia Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jia Gu. The network helps show where Jia Gu may publish in the future.

Co-authorship network of co-authors of Jia Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Jia Gu. A scholar is included among the top collaborators of Jia Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jia Gu. Jia Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Shiyuan, et al.. (2024). A single‐centre, real‐world study of BTK inhibitors for the initial treatment of MYD88mut/CD79Bmut diffuse large B‐cell lymphoma. Cancer Medicine. 13(4). e7005–e7005. 6 indexed citations
2.
Ge, Tong, Ke Shen, Hui Luo, et al.. (2024). Novel heterozygous mutations of TNFRSF13B in EBV-associated T/NK lymphoproliferative diseases (EBV-T/NK-LPDs). SHILAP Revista de lepidopterología. 6(1). e00180–e00180. 1 indexed citations
3.
Jin, Jin, Ting Sun, Man Zhang, et al.. (2023). EBV-Encoded MicroRNA-BART17-3p Targets DDX3X and Promotes EBV Infection in EBV-Associated T/Natural Killer–Cell Lymphoproliferative Diseases. Open Forum Infectious Diseases. 10(11). ofad516–ofad516. 4 indexed citations
4.
Zhang, Shuo, et al.. (2022). The lipid rafts in cancer stem cell: a target to eradicate cancer. Stem Cell Research & Therapy. 13(1). 432–432. 30 indexed citations
5.
Shi, Yaning, et al.. (2022). Wnt5a/Ror2 promotes vascular smooth muscle cells proliferation via activating PKC. Folia Histochemica et Cytobiologica. 60(3). 271–279. 4 indexed citations
6.
Luo, Hui, Wenbing Liu, Jin Jin, et al.. (2022). Clinical and genetic characterization of Epstein-Barr virus–associated T/NK-cell lymphoproliferative diseases. Journal of Allergy and Clinical Immunology. 151(4). 1096–1109. 10 indexed citations
7.
Zhang, Shuo, Neng Zhu, Jia Gu, et al.. (2022). Crosstalk between Lipid Rafts and Aging: New Frontiers for Delaying Aging. Aging and Disease. 13(4). 1042–1042. 12 indexed citations
8.
Zhang, Chanjuan, Neng Zhu, Hongfang Li, et al.. (2022). New dawn for cancer cell death: Emerging role of lipid metabolism. Molecular Metabolism. 63. 101529–101529. 44 indexed citations
9.
Gu, Jia, Neng Zhu, Hongfang Li, et al.. (2022). Cholesterol homeostasis and cancer: a new perspective on the low-density lipoprotein receptor. Cellular Oncology. 45(5). 709–728. 35 indexed citations
10.
Gu, Jia, Neng Zhu, Hongfang Li, et al.. (2022). Ezetimibe and Cancer: Is There a Connection?. Frontiers in Pharmacology. 13. 831657–831657. 17 indexed citations
11.
Gu, Jia, Hongyan Ji, Caixia Chen, et al.. (2022). Detection of cytomegalovirus (CMV) by digital PCR in stool samples for the non-invasive diagnosis of CMV gastroenteritis. Virology Journal. 19(1). 183–183. 7 indexed citations
12.
Zhu, Neng, Tanjun Zhao, Hongfang Li, et al.. (2022). Involvement of LDL and ox-LDL in Cancer Development and Its Therapeutical Potential. Frontiers in Oncology. 12. 803473–803473. 66 indexed citations
13.
Shen, Ke, Li Yang, Haodong Cai, et al.. (2021). Inherited Genetic Susceptibility to Nonimmunosuppressed Epstein-Barr Virus-associated T/NK-cell Lymphoproliferative Diseases in Chinese Patients. Current Medical Science. 41(3). 482–490. 11 indexed citations
14.
Ji, Hongyan, Xiaolu Long, Jia Gu, et al.. (2021). Longitudinal Monitoring of Plasma Circulating Tumour DNA Enables the Prediction of Early Relapse in Patients with Non-Hodgkin Lymphoma: A Case Series. Diagnostics. 11(11). 2055–2055. 2 indexed citations
15.
Lou, Yaoyao, Caixia Chen, Xiaolu Long, et al.. (2020). Detection and Quantification of Chimeric Antigen Receptor Transgene Copy Number by Droplet Digital PCR versus Real-Time PCR. Journal of Molecular Diagnostics. 22(5). 699–707. 39 indexed citations
16.
Guo, Jing-Ming, Jia Gu, Chen Zeng, et al.. (2020). Clinical Characteristics of Hemophagocytic Lymphohistiocytosis Associated with Non-Hodgkin B-Cell Lymphoma: A Multicenter Retrospective Study. Clinical Lymphoma Myeloma & Leukemia. 21(2). e198–e205. 6 indexed citations
17.
Zhang, Peiling, Chen Zeng, Jiali Cheng, et al.. (2019). Determination of Epstein-Barr Virus–Infected Lymphocyte Cell Types in Peripheral Blood Mononuclear Cells as a Valuable Diagnostic Tool in Hematological Diseases. Open Forum Infectious Diseases. 6(5). ofz171–ofz171. 15 indexed citations
18.
Sheng, Lingshuang, et al.. (2019). Novel mutations of STXBP2 and LYST associated with adult haemophagocytic lymphohistiocytosis with Epstein-Barr virus infection: a case report. BMC Medical Genetics. 20(1). 34–34. 6 indexed citations
19.
Long, Xiaolu, Qian Xu, Yaoyao Lou, et al.. (2019). The Utility of Non-Invasive Liquid Biopsy for Mutational Analysis and Minimal Residual Disease Assessment in Extramedullary Multiple Myeloma. SSRN Electronic Journal. 2 indexed citations
20.
Liang, Xue, Jia Gu, Lei Zhao, et al.. (2018). PAX5 haploinsufficiency induce cancer cell dormancy in Raji cells. Experimental Cell Research. 367(1). 30–36. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026